Skip to content
Disclosery

8VC GP I, LLC

Follow

13F filer, CIK 1667766, AUSTIN, TX

8VC GP I, LLC reported $77,802,906 across 2 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-12.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001193125-25-277792

Period
2025-09-30
Reported value
$77.8M
Holdings
2
Top 10 weight
100%
New
0
Sold out
0

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
JOBYreduced-4,798,333-$77.4M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0001193125-25-277792, largest first. % of portfolio is the value over $77,802,906, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
JOBYJOBY AVIATION INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 14,395,000 shares; 2024Q4: 9,596,667 shares; 2025Q1: 9,596,667 shares; 2025Q2: 9,596,667 shares; 2025Q3: 4,798,334 shares 4,798,334$77.4M99.54%-4,798,333Timeline
Senti Biosciences, Inc.Senti Biosciences, Inc.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 253,755 shares; 2024Q4: 253,755 shares; 2025Q1: 253,755 shares; 2025Q2: 253,755 shares; 2025Q3: 253,755 shares 253,755$358K0.46%0

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001193125-25-277792 base2025-11-12acceptance time not in the bulk data set